| Literature DB >> 29181640 |
Keumhan Noh1, You Ra Kang2, Mahesh Raj Nepal2, Rajina Shakya2, Mi Jeong Kang2, Wonku Kang3, Sangkyu Lee4, Hye Gwang Jeong5, Tae Cheon Jeong6.
Abstract
The intestinal mucosa and liver have long been considered as the main sites of drug metabolism, and the contribution of gut microbiota to drug metabolism has been under-estimated. However, it is now generally accepted that the gut microbiota plays an important role in drug metabolism prior to drug absorption or during enterohepatic circulation via various microbial enzymatic reactions in the intestine. Moreover, some drugs are metabolized by gut microbiota to specific metabolite(s) that cannot be formed in the liver. More importantly, the metabolism of drugs by gut microbiota prior to absorption can alter the systemic bioavailability of certain drugs. Therefore, understanding drug metabolism by gut microbiota is critical for explaining changes in the pharmacokinetics of drugs, which may cause significant alterations in drug-induced pharmacodynamics and toxicities. In this review, we describe recent progress with regard to the role of metabolism by gut microbiota in some drug-induced alterations of either pharmacological or toxicological effects to emphasize the clinical importance of gut microbiota for safe and effective use of drugs.Entities:
Keywords: Drug metabolism; Gut microbiota; Pharmacodynamics; Pharmacokinetics; Toxicity
Mesh:
Substances:
Year: 2017 PMID: 29181640 DOI: 10.1007/s12272-017-0986-y
Source DB: PubMed Journal: Arch Pharm Res ISSN: 0253-6269 Impact factor: 4.946